The Wistar Institute Strengthens AI-Driven Drug Discovery with Recruitment of Computational Biophysicist Guangfeng Zhou

Wistar announces the appointment of Guangfeng Zhou, Ph.D., as assistant professor in the Center for Advanced Therapeutics (CAT). Zhou develops computational methods that combine physics-based molecular modeling with artificial intelligence (AI) to predict how small molecules bind to protein targets.